🎯 What makes MyoScreen™ unique:
→ Biobank of 65+ donors covering 10+ diseases (DMD, DM1, DM2, FSHD, Pompe, SMA, PMM…)
→ Optimized culture for primary myoblasts = maximum clinical relevance
→ Flexible metabolic disorder modeling
→ Custom donor sourcing on demand
→ Compatible with immortalized cell lines
Â
đź’ˇ The goal? Accelerate therapy discovery by bridging the gap between lab and patient.
CYTOO combines proprietary biobanking expertise with access to samples through established partners, offering researchers unmatched flexibility.
Â
🚀 Ready to power your next discovery with more predictive data?
đź“© Let’s discuss how MyoScreen™ can support your research program. Contact us today!


